The Latest Breaking News from TMO

Could Thermo Fisher Scientific Inc. (NYSE:TMO) be the unsung hero of the biopharma sector's future? While its stock performance has recently lagged, analysts are betting on a major turnaround driven by strategic acquisitions and robust growth potential. William Blair initiated coverage on Tuesday on Thermo Fisher Scientific, citing a strong…

While Thermo Fisher Scientific has underperformed the broader market over the past year, Wall Street analysts continue to hold a bullish view of the stock’s long-term prospects.

Even though Waters Corporation has outshined the industry peers over the past year, Wall Street analysts maintain a cautiously optimistic outlook on the stock’s prospects.

While TMO stock has represented one of the biggest market losers, a sentiment reversal could be in the works.

Thermo Fisher Scientific has notably underperformed the Nasdaq Composite over the past year, yet analysts remain bullish about the stock’s prospects.

Although Thermo Fisher Scientific has lagged behind the broader market over the past year, Wall Street analysts maintain a bullish outlook on the stock’s prospects.

The Newcastle director of rugby was hit with a six-match ban last week

Steve Diamond’s season-ending ban came because he hit out at a group of match-day officials before telling the TMO he should retire

Thermo Fisher Scientific will release its first-quarter earnings later this month, and analysts anticipate bottom-line to remain unchanged year over year.